<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36138349</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2377</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>22</Day></PubDate></JournalIssue><Title>BMC neurology</Title><ISOAbbreviation>BMC Neurol</ISOAbbreviation></Journal><ArticleTitle>Colostomy as a definitive treatment in an ALS patient with acute colonic Pseudo-obstruction refractory to medical management, a case report.</ArticleTitle><Pagination><StartPage>366</StartPage><MedlinePgn>366</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">366</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12883-022-02893-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease, and ALS patients may experience disturbed gastrointestinal motility often resulting in acute colonic pseudo-obstruction (ACPO). There is currently a paucity in the literature to guide the treatment of patients with both ALS and ACPO.</AbstractText><AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">Here we describe a 39-year-old male patient with advanced ALS who developed ACPO. His condition was refractory to both medical and procedural managements including polyethylene glycol, senna, and docusate suppository, metoclopramide, linaclotide, erythromycin, prucalopride, neostigmine, and repeated colonoscopies. He ultimately underwent successful colostomy for palliation. Here we report the peri-operative multidisciplinary approach taken with this case, the surgical procedures, the potential risks, and the outcome.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The patient is delighted with the result and requested publication of this case to raise awareness of constipation in ALS patients and promote the consideration of colostomy as a treatment option for patients with ileus resistant to conservative management. Ultimately, a multidisciplinary team approach is required to properly assess the risks and benefits to achieve good clinical outcomes.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Guanghao</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5181-3659</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, 52333, USA. Guanghao-liu@uiowa.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hrabe</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Gastrointestinal, Minimally invasive and Bariatric Surgery, University of Iowa Hospitals and Clinics, Iowa City, 52333, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Rolando</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Pulmonary, Critical Care and Occupational Medicine, University of Iowa Hospitals and Clinics, Iowa City, 52333, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Neurol</MedlineTA><NlmUniqueID>100968555</NlmUniqueID><ISSNLinking>1471-2377</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>10041-19-7</RegistryNumber><NameOfSubstance UI="D004143">Dioctyl Sulfosuccinic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>3982TWQ96G</RegistryNumber><NameOfSubstance UI="D009388">Neostigmine</NameOfSubstance></Chemical><Chemical><RegistryNumber>3WJQ0SDW1A</RegistryNumber><NameOfSubstance UI="D011092">Polyethylene Glycols</NameOfSubstance></Chemical><Chemical><RegistryNumber>63937KV33D</RegistryNumber><NameOfSubstance UI="D004917">Erythromycin</NameOfSubstance></Chemical><Chemical><RegistryNumber>L4YEB44I46</RegistryNumber><NameOfSubstance UI="D008787">Metoclopramide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003112" MajorTopicYN="Y">Colonic Pseudo-Obstruction</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003125" MajorTopicYN="N">Colostomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004143" MajorTopicYN="N">Dioctyl Sulfosuccinic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004917" MajorTopicYN="N">Erythromycin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008787" MajorTopicYN="N">Metoclopramide</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009388" MajorTopicYN="N">Neostigmine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011092" MajorTopicYN="N">Polyethylene Glycols</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Acute colonic pseudo-obstruction</Keyword><Keyword MajorTopicYN="N">Colostomy</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>22</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36138349</ArticleId><ArticleId IdType="pmc">PMC9494822</ArticleId><ArticleId IdType="doi">10.1186/s12883-022-02893-x</ArticleId><ArticleId IdType="pii">10.1186/s12883-022-02893-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344(22):1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10(5&#x2013;6):310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Logroscino G, Traynor BJ, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41(2):118&#x2013;130. doi: 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Samara VC, Jerant P, Gibson S, Bromberg M. Bowel, bladder, and sudomotor symptoms in ALS patients. J Neurol Sci. 2021;427:117543. doi: 10.1016/j.jns.2021.117543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117543</ArticleId><ArticleId IdType="pubmed">34182195</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu A. Neostigmine: an alternative treatment for constipation. Dynamics. 2005;16(1):13&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">15835453</ArticleId></ArticleIdList></Reference><Reference><Citation>Toepfer M, Folwaczny C, Klauser A, Riepl RL, Muller-Felber W, Pongratz D. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 1999;1(1):15&#x2013;19. doi: 10.1080/146608299300079484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608299300079484</ArticleId><ArticleId IdType="pubmed">12365061</ArticleId></ArticleIdList></Reference><Reference><Citation>Toepfer M, Schroeder M, Klauser A, et al. Delayed colonic transit times in amyotrophic lateral sclerosis assessed with radio-opaque markers. Eur J Med Res. 1997;2(11):473&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pubmed">9385117</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato K, Namba R, Hayabara T, Kashihara K, Morimoto K. Autonomic nervous disorder in motor neuron disease: a study of advanced stage patients. Intern Med. 1995;34(10):972&#x2013;975. doi: 10.2169/internalmedicine.34.972.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.34.972</ArticleId><ArticleId IdType="pubmed">8563098</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcucci V, Diko S, Christian D. Gallstone ileus in a patient with amyotrophic lateral sclerosis: a case report. Int J Surg Case Rep. 2021;79:210&#x2013;214. doi: 10.1016/j.ijscr.2021.01.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijscr.2021.01.047</ArticleId><ArticleId IdType="pmc">PMC7820309</ArticleId><ArticleId IdType="pubmed">33482450</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawlings C. Management of postcaesarian Ogilvie's syndrome and their subsequent outcomes. Aust N Z J Obstet Gynaecol. 2010;50(6):573&#x2013;574. doi: 10.1111/j.1479-828X.2010.01214.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1479-828X.2010.01214.x</ArticleId><ArticleId IdType="pubmed">21133870</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakir AJ, Sajid MS, Kianifard B, Baig MK. Ogilvie's syndrome-related right colon perforation after cesarean section: a case series. Kaohsiung J Med Sci. 2011;27(6):234&#x2013;238. doi: 10.1016/j.kjms.2010.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kjms.2010.11.006</ArticleId><ArticleId IdType="pubmed">21601169</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell T, Paul D, Scott-Morgan P, Wright M, Kenefick N. Thriving, not just surviving, with motor neurone disease. The outcome of the first pre-emptive &#x2018;triple-ostomy&#x2019;. Oxford Medical Case Reports. 2019;2019(10). 10.1093/omcr/omz109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6874861</ArticleId><ArticleId IdType="pubmed">31798922</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben Ameur H, Boujelbene S, Beyrouti MI. [Treatment of acute colonic pseudo-obstruction (Ogilvie's syndrome). Systematic review]. Tunis Med 2013;91(10):565&#x2013;72. (https://www.ncbi.nlm.nih.gov/pubmed/24281995).</Citation><ArticleIdList><ArticleId IdType="pubmed">24281995</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>